Indian marketers argue publicly with ads

Published on .

Most Popular
BOMBAY - Dietary supplement marketers Parry's Nutraceuticals and Sanat Products have become embroiled in an advertising spat of claim and counter-claim.

Parry's, part of the massive Murugappa Group, promotes its Spirulina dietary supplement as approved by the U.S. Food and Drug Administration. It's ad headline reads: "U.S. FDA -- The ingredients of the better Spirulina."

But Sanat Products, a subsidiary of the Dabur group, has filed a complaint about that ad to the Advertising Standards Council of India and is countering Parry's FDA claim with what it calls a "public interest ad."

"Consumers of Spirulina do not be misled," its headline announces, followed by copy stating: "The U.S. FDA does not approve Spirulina ... for human consumption in the USA."

Parry's response: It has filed its own complaint with the ASCI.

Copyright December 2000, Crain Communications Inc.

In this article: